Advertisement
Advertisement

IRON

IRON logo

Disc Medicine Inc

63.53
USD
-1.47
-2.26%
Dec 18, 15:59 UTC -5
Closed
...

Disc Medicine Inc Profile

About

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

Info & Links

CEO

John Quisel

Headquarters

321 Arsenal Street, Suite 101
Watertown, MA 02472, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

19

Employees

74

Disc Medicine Inc Statistics

Valuation Measures

Market Capitalization2

1.89B

Enterprise Value

1.70B

Enterprise Value/EBITDA(ttm)

-13.29

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.12

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-25.24%

Return on Invested Capital(ttm)

-25.88%

Return on Assets(ttm)

-23.96%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-127.80M

Net Income Available to Common(ttm)

-103.48M

Diluted EPS(ttm)

-3.98

Share Statistics

Beta (5Y Monthly)

0.76

52-Week Change

14.26%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

29.76M

Dividend Yield

0.00%

Float4

28.50M

% Held by Insiders

4.24%

% Held by Institutions

83.70%

Balance Sheet

Total Cash(mrq)

487.36M

Total Cash Per Share(mrq)

16.38

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

19.36%

Quick Ratio(mrq)

19.36%

Book Value Per Share(mrq)

15.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.22

Free Cash Flow(ytd)

-66.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement